Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
Journal of Lipid Mediators and Cell Signalling|December 1, 1996
PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cellsY Denizot, F Dupuis, F Trimoreau, et al.Journal of Lipid Mediators and Cell Signalling|May 1, 1997
Presence and metabolism of lyso platelet-activating factor in human bone marrowY Denizot, F Rougier, F Dupuis, et al.Journal of Lipid Mediators and Cell Signalling|March 1, 1997
PLA2 activity in Tetrahymena pyriformis. Effects of inhibitors and stimulatorsP Kovács, G CsabaJournal of Lipid Mediators and Cell Signalling|March 1, 1997
Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitorsG Feuerstein, R Rabinovici, J Leor, et al.Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibitionC Binisti, E Touboul, C Mounier, et al.Journal of Lipid Mediators and Cell Signalling|December 1, 1996
Pharmacological characterisation of a new model of antigen-induced pulmonary late-phase reaction in the conscious guinea pig which uses additional polymyxin B inhalationH O Heuer, B Wenz, H M Jennewein, et al.Journal of Lipid Mediators and Cell Signalling|December 1, 1996
Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit plateletsM A Packham, D H Ruben, M L RandJournal of Lipid Mediators and Cell Signalling|May 1, 1997
Characterization of the carbohydrate structures of apolipoprotein H through concanavalin A affinity chromatographyR Gambino, G Ruiu, G Pagano, et al.Journal of Lipid Mediators and Cell Signalling|January 1, 1996
L-Arginine infusion after ischaemia-reperfusion of rat kidney enhances lipid peroxidationJ P Cristol, C Thiemermann, M C Guérin, et al.Journal of Lipid Mediators and Cell Signalling|May 1, 1996
Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SARL Le Texier, E Favre, N Ronzani, et al.Pageof 19